Sagar Sengupta

11PUBLICATIONS
47CO-AUTHORS
Tumour immunologyHaematological tumoursMemory and attentionMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 19, 2026
BLM regulates MALT1-driven NF-κB signalling and is targetable in B-cell malignancies.

|Mar 05, 2026
K63-linked ubiquitylation of RMI1 by RNF8 is essential to its recruitment to stalled forks.

Rimpy Arun, Sadananda Kumbhakar, Tavleen Kaur

|Mar 04, 2025
p53 regulates DREAM complex-mediated repression in a p21-independent manner.

Ritu Agrawal, Sagar Sengupta

|Feb 25, 2025
Phosphorylated BLM peptide acts as an agonist for DNA damage response.

Ritu Agrawal, Himanshi Agarwal, Chetana Mukherjee

|Jun 30, 2023
A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response.

Animesh Kar, Dolly Jain, Sandeep Kumar

|Aug 09, 2021
CDX2 inducible microRNAs sustain colon cancer by targeting multiple DNA damage response pathway factors.

Swati Priya, Ekjot Kaur, Swati Kulshrestha

Pageof 2

Frequent Collaborators

4 joint publications

Avinash Bajaj

3 joint publications

Arnab Mukhopadhyay

3 joint publications

Sandeep Kumar

3 joint publications

Sanjay Pal